Evidence map›Paper›PMID 35501862›Full record

ArticleVirology journal2022

A fast extraction-free isothermal LAMP assay for detection of SARS-CoV-2 with potential use in resource-limited settings.

Kathleen Gärtner, Harry Meleke, Mercy Kamdolozi, David Chaima, Lyson Samikwa, Mary Paynter, Maggie Nyirenda Nyang'Wa, Elaine Cloutman-Green, Eleni Nastouli, Nigel Klein and 3 more

Open access · goldAbstract read
In one paragraph

Article in Virology journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Kathleen GärtnerGreat Ormond Street Institute of Child Health, University College London, London, UK. k.gartner@ucl.ac.uk.ORCID 0000-0003-2221-6251
Harry MelekePathology Department, Kamuzu University of Health Sciences, Blantyre, Malawi.
Mercy KamdoloziPathology Department, Kamuzu University of Health Sciences, Blantyre, Malawi.
David ChaimaPathology Department, Kamuzu University of Health Sciences, Blantyre, Malawi.
Lyson SamikwaPathology Department, Kamuzu University of Health Sciences, Blantyre, Malawi.
Mary PaynterSt. George's University Hospitals London, London, UK.
Maggie Nyirenda Nyang'WaGreat Ormond Street Institute of Child Health, University College London, London, UK.
Elaine Cloutman-GreenGreat Ormond Street Hospital, NHS Foundation Trust, London, UK.
Eleni NastouliGreat Ormond Street Institute of Child Health, University College London, London, UK.
Nigel KleinGreat Ormond Street Institute of Child Health, University College London, London, UK.
Tonney NyirendaPathology Department, Kamuzu University of Health Sciences, Blantyre, Malawi.
Chisomo MsefulaPathology Department, Kamuzu University of Health Sciences, Blantyre, Malawi.
Dagmar G AlberGreat Ormond Street Institute of Child Health, University College London, London, UK.
Kamuzu Central Hospital · MWGreat Ormond Street Hospital · GBGreat Ormond Street Hospital for Children NHS Foundation Trust · GBSt George’s University Hospitals NHS Foundation Trust · GBUniversity College Hospital · GB

Funding

Malawi HIV Implementation Research Scientist Training Program (MHIRST)D43TW010060 · FIC · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MINA CHRISTINE HOSSEINIPOUR, Victor Mwapasa · 2015 to 2026
$3.8M
FIC NIH HHS D43 TW010060
6 · The paper itself

Abstract

backgroundTo retain the spread of SARS-CoV-2, fast, sensitive and cost-effective testing is essential, particularly in resource limited settings (RLS). Current standard nucleic acid-based RT-PCR assays, although highly sensitive and specific, require transportation of samples to specialised laboratories, trained staff and expensive reagents. The latter are often not readily available in low- and middle-income countries and this may significantly impact on the successful disease management in these settings. Various studies have suggested a SARS-CoV-2 loop mediated isothermal amplification (LAMP) assay as an alternative method to RT-PCR.

methodsFour previously published primer pairs were used for detection of SARS-CoV-2 in the LAMP assay. To determine optimal conditions, different temperatures, sample input and incubation times were tested. Ninety-three extracted RNA samples from St. George's Hospital, London, 10 non-extracted nasopharyngeal swab samples from Great Ormond Street Hospital for Children, London, and 92 non-extracted samples from Queen Elisabeth Central Hospital (QECH), Malawi, which have previously been tested for SARS-Cov-2 by quantitative reverse-transcription RealTime PCR (qRT-PCR), were analysed in the LAMP assay.

resultsIn this study we report the optimisation of an extraction-free colourimetric SARS-CoV-2 LAMP assay and demonstrated that a lower limit of detection (LOD) between 10 and 100 copies/µL of SARS-CoV-2 could be readily detected by a colour change of the reaction within as little as 30 min. We further show that this assay could be quickly established in Malawi, as no expensive equipment is necessary. We tested 92 clinical samples from QECH and showed the sensitivity and specificity of the assay to be 86.7% and 98.4%, respectively. Some viral transport media, used routinely to stabilise RNA in clinical samples during transportation, caused a non-specific colour-change in the LAMP reaction and therefore we suggest collecting samples in phosphate buffered saline (which did not affect the colour) as the assay allows immediate sample analysis on-site.

conclusionSARS-CoV-2 LAMP is a cheap and reliable assay that can be readily employed in RLS to improve disease monitoring and management.

Indexed as

COVID-19SARS-CoV-2ChildHumansMolecular Diagnostic TechniquesNucleic Acid Amplification TechniquesRNARNAExtraction-free LAMPqRT-PCRResource-limited settingsSARS-CoV-2

Identifiers

PMID35501862
PMCPMC9059459
OpenAlexW4225273051

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.